Sucampo Pharmaceuticals, Inc., Reports First Quarter 2014 Financial and Operating Results
May 07, 2014 16:02 ET
|
Sucampo Pharmaceuticals Inc
Strong Financial Performance Driven by Year over Year Income and Revenue Growth
Company to host conference call today at 5:00 pm Eastern
BETHESDA, Md., May 7, 2014 (GLOBE NEWSWIRE) -- Sucampo...
Sucampo Announces New Data on AMITIZA and Opioid-Induced Constipation Published Online in Pain Medicine Journal
May 06, 2014 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 6, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, announced that its recent study, "A Randomized Study of...
Sucampo Announces Clinical Data on Lubiprostone to be Presented at Two Upcoming Scientific Conferences
May 01, 2014 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 1, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. ("Sucampo") (Nasdaq:SCMP), a global biopharmaceutical company, today announced that clinical data for lubiprostone will be...
Sucampo Pharmaceuticals Announces First Quarter 2014 Results and Operating Highlights Teleconference and Webcast
April 30, 2014 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., April 30, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo"), a global biopharmaceutical company, today announced that it will host a webcast and...
Preclinical Data for Lubiprostone and Unoprostone Isopropyl to be Presented at Experimental Biology Conference 2014
April 25, 2014 16:08 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., April 25, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. ("Sucampo") (Nasdaq:SCMP), a global biopharmaceutical company, today announced that preclinical data for lubiprostone...
Sucampo Co-Founder and Chairman Emeritus, Dr. Ryuji Ueno, to Receive Visionary Award From the Foundation Fighting Blindness
March 25, 2014 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., March 25, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that the Foundation Fighting Blindness...
Sucampo and Takeda Announce Update on Liquid Formulation Program for AMITIZA(R) (lubiprostone)
March 14, 2014 17:29 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., March 14, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharma Americas, LLC, a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), and its development and...
Sucampo Receives Notice that Second Indication for AMITIZA for Opioid-Induced Constipation Is Not Approved by Medicines and Healthcare Products Regulatory Agency in U.K.
March 12, 2014 20:00 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., March 12, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP) today announced that Sucampo Pharma Europe, Ltd., its wholly owned subsidiary, has received a...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2014 ROTH Conference
March 05, 2014 16:02 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., March 5, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo and National Cherry Blossom Festival Announce Sucampo as Host and 'Step Into Spring' Program Sponsor for 2014
March 04, 2014 10:00 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md. and WASHINGTON, March 4, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP) and the National Cherry Blossom Festival (Festival) today announced their ongoing...